In B-cell lymphomas, heterozygous gain-of-function mutations of residues within the catalytic SET domain of EZH2 occur in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma, and result in enhanced H3K27 trimethylation and transcriptional repression [28]. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.